Discover The New World of Genomics

OSUWexnerbloglogo2014 Discover The New World of Genomics. Genetic testing has come a long, long way. Not only can individuals find out where their ancestors came from but they can also find out if they carry genes that can cause disease in them or their children. The speed that genomics is growing is so fast that what was state of the art just a year ago is now antiquated and obsolete. On this CME webcast, we’re going to show you where genomics is now and where it’s going to be in the near future. To discuss this exciting topic, we have two guests joining our moderator in the studio today. We’re pleased to welcome two genetic counselors from the Ohio State University Division of Human Genetics. We have Associate Professor of Internal Medicine, Amy Sturm and also Associate Professor of Internal Medicine, Kevin Sweet.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE genomic medicine; and REVIEW early triumphs, and potential limitations, of genomic medicine (Guiding treatment, Risk assessment, Early detection/prevention and Diagnostics).

You’ll also learn about the following:

  • Whole genome sequencing
  • Limitations in genomic disease profiling
  • Epigenetics
  • Cancer genomics and cancer classifications
  • FDA regulation of genome sequencing companies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education for Familial Heart Disease

OSUWexnerbloglogo2014 On-line Education for Familial Heart Disease. There are a lot more inherited heart diseases than anyone could have conceived of back in the 1970s. In the studio to provide an update on familial heart disease is cardiologist and professor of internal medicine as well as director of the OSU division of human genetics, Dr. Ray Hershberger. Also, joining us is genetic counselor and associate professor of internal medicine, Amy Sturm.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Describe the current state of genetic and genomic testing in cardiovascular medicine; and EXPLAIN the rationale, benefits, and limitations of cardiovascular genetics and genomics evaluation.

You’ll also learn about the following:

  • Family history in the era of electronic medical records
  • Advances in genetic testing
  • Whole genome sequencing
  • When to order genetic counseling
  • Clinical approach to the patient with a family history of sudden death
  • Clinical approach to the patient with a family history of CHF

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.